Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
GHK-Cus gene modulation capacity was documented in a landmark microarray analysis by Pickart et al., identifying 4,000+ gene targets including VEGF upregulation (angiogenesis), SOD2 upregulation (oxidative defense), and downregulation of pro-inflammatory cytokine genes including TNF- and IL-6
Each unit is produced and distributed according to standardized laboratory preparation guidelines
State-by-state availability for the Longevity service specifically, independent clinical trial data on the compounded formulations, and ingredient-level drug interaction data were not confirmed in the materials reviewed and are omitted rather than assumed
See also [edit] References [edit] 1 2 World Health Organization (2009)
